Fresenius Medical Care AG (ETR:FME – Get Free Report)’s stock price passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of €40.89 ($42.59) and traded as high as €45.92 ($47.83). Fresenius Medical Care shares last traded at €45.56 ($47.46), with a volume of 509,562 shares changing hands.
Fresenius Medical Care Trading Up 1.8 %
The firm has a 50-day moving average of €45.14 and a 200-day moving average of €40.89. The company has a debt-to-equity ratio of 82.24, a quick ratio of 0.80 and a current ratio of 1.37. The firm has a market capitalization of $13.72 billion, a P/E ratio of 20.82, a price-to-earnings-growth ratio of 0.42 and a beta of 0.86.
Fresenius Medical Care Company Profile
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Featured Stories
- Five stocks we like better than Fresenius Medical Care
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Chaos and Cash: Finding Opportunity in Volatility
- Growth Stocks: What They Are, What They Are Not
- Realty Income: An Anchor in Volatile Markets
- Investing In Automotive Stocks
- Autodesk Designs Value for Investors: Uptrend Set to Continue
Receive News & Ratings for Fresenius Medical Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care and related companies with MarketBeat.com's FREE daily email newsletter.